QA: Omeros CORP in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001285819_2022_Omeros_CORP.pdf

Logs

Graph

Absolute values for 0001285819, Omeros CORP

  xvar xval
0 AssetsCurrent 247,889,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 171,379,000
4 LiabilitiesCurrent 51,789,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold -627,828
8 SellingGeneralAndAdministrativeExpense 42,001,394
9 ResearchAndDevelopmentExpense 126,320,415
10 remainder_Expenses 17,433,684
11 remainder_Revenues 15,833,549
12 remainder_NetIncome -10,412,539
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 419,268,000
1 Liabilities 51,789,000
2 Expenses 185,127,665
3 Revenues 15,833,549
4 StockholdersEquity 367,479,000
5 NetIncome -179,706,655
6 ComprehensiveNetIncome -179,706,655
7 BaseVar 341,215,376
8 EconomicCapitalRatiobeforeLimitedLiability 2.64
9 EconomicCapitalRatio 3.45

Edgar->Model Mapping

Feature Distribution

Change over Time